Evidence map›Paper›PMID 29140772›Full record

Trial reportJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Role of Patient Coping Strategies in Understanding the Effects of Early Palliative Care on Quality of Life and Mood.

Joseph A Greer, Jamie M Jacobs, Areej El-Jawahri, Ryan D Nipp, Emily R Gallagher, William F Pirl, Elyse R Park, Alona Muzikansky, Juliet C Jacobsen, Vicki A Jackson and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joseph A GreerJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
Jamie M JacobsJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
Areej El-JawahriJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
Ryan D NippJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
Emily R GallagherJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
William F PirlJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
Elyse R ParkJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
Alona MuzikanskyJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
Juliet C JacobsenJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
Vicki A JacksonJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.
Jennifer S TemelJoseph A. Greer, Jamie M. Jacobs, Areej El-Jawahri, Ryan D. Nipp, Emily R. Gallagher, Elyse R. Park, Alona Muzikansky, Juliet C. Jacobsen, Vicki A. Jackson, and Jennifer S. Temel, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and William F. Pirl, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL.

Funding

A Randomized trial of early palliative care for newly diagnosed cancer patientsR01NR012735 · NINR · MASSACHUSETTS GENERAL HOSPITAL · PI TEMEL, JENNIFER SUE · 2011 to 2015
$2.1M
Optimizing Palliative and End of Life Care for Patients with CancerK24CA181253 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TEMEL, JENNIFER SUE · 2014 to 2018
$737k
NCI NIH HHS K24 CA181253NINR NIH HHS R01 NR012735
6 · The paper itself

Abstract

Purpose The early integration of oncology and palliative care (EIPC) improves quality of life (QOL) and mood for patients with advanced cancer. However, the mechanisms by which EIPC benefits these outcomes remain unclear. We therefore examined whether EIPC improved patients' coping strategies and if changes in coping accounted for intervention effects on QOL and depressive symptoms. Patients and Methods For this secondary analysis of an EIPC trial, we examined data from 350 patients with newly diagnosed incurable lung or GI cancer. Participants completed assessments of QOL (Functional Assessment of Cancer Therapy-General), depressive symptoms (Patient Health Questionnaire-9), and coping (Brief COPE) at baseline and 24 weeks. We used linear regression to test intervention effects on use of coping strategies and mediation regression models with bias-corrected bootstrapping to examine whether improvements in coping mediated the effects of early palliative care on patient-reported outcomes. Results Compared with usual oncology care, EIPC significantly increased patient use of approach-oriented coping strategies ( B = 1.09; SE = 0.44; P = .01) and slightly reduced use of avoidant strategies ( B = -0.44; SE = 0.23; P = .06) from baseline to 24 weeks. Also, the increased use of approach-oriented coping and reduction in avoidant coping were associated with higher QOL and lower depressive symptoms at 24 weeks. The positive changes in approach-oriented coping, but not avoidant coping, significantly mediated the effects of EIPC on QOL (indirect effect, 1.27; 95% CI, 0.33 to 2.86) and depressive symptoms (indirect effect, -0.39; 95% CI, -0.87 to -0.08). Conclusion Patients with incurable cancer who received EIPC showed increased use of approach-oriented coping, which was associated with higher QOL and reduced depressive symptoms. Palliative care may improve these outcomes by providing patients with the skills to cope effectively with life-threatening illness.

Indexed as

Adaptation, PsychologicalPatient ParticipationQuality of LifeAffectAgedDepressionFemaleGastrointestinal NeoplasmsHumansLung NeoplasmsMaleMiddle AgedOutcome Assessment, Health CarePalliative CareSurveys and Questionnaires

Identifiers

PMID29140772
PMCPMC5756320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.